AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (513.8 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

The abnormal splicing regulation network caused by synonymous mutations in FBN1 exon 39 leads to Marfan syndrome

Fudan Wua,1Mingjie Lib,1( )Xuan ZhouaQianyun WangcYan’an Wua( )
Department of Clinical Laboratory, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China
Department of Clinical Laboratory, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian 350000, China

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).

1 These authors contributed equally to this work and were listed as co-first authors.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Article number: 101371

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wu F, Li M, Zhou X, et al. The abnormal splicing regulation network caused by synonymous mutations in FBN1 exon 39 leads to Marfan syndrome. Genes & Diseases, 2025, 12(3): 101371. https://doi.org/10.1016/j.gendis.2024.101371

307

Views

2

Downloads

1

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 18 April 2023
Published: 03 July 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).